Deals and Financing

Warp Funds Automated Chemistry Infrastructure

Source-gap recovery: Warp Sciences emerged from stealth on 22 October with $215 million of disclosed funding led by Lightspeed. The investment targets US-based AI, robotics and medicinal-chemistry services, but no customer-throughput or drug-discovery success…

Roche and Hansoh Expand ADC Alliance

Hansoh Pharma and Roche entered a second antibody drug conjugate collaboration covering two undisclosed Hansoh preclinical programs and multiple Roche-proposed targets using Hansoh’s proprietary ADC platform. Hansoh will receive $400 million upfront and $110…